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ABSTRACT
Objective: Acute rheumatic fever is still one of 
the leading causes of mortality and morbidity due 
to heart disease in developing countries. Carditis 
is the most important manifestation of the 
disease and there are still difficulties in diagnosis. 
Cardiac troponin-T measurement has been 
found to be valuable in recognition of cardiac 
injury in various disease states. We investigated 
the cardiac troponin-T levels in patients with 
acute rheumatic fever and searched for a 
difference between patients with and without 
carditis.
Methods: The study group consisted of 21 
patients; 12 were girls and 9 were boys. Their 
age ranged between 6-16.5 years 
(mean±SD=11.9±2.5 yrs). Seven patients had 
only arthritis; 10 patients had both carditis and 
arthritis; and 4 patients had chorea as clinical 
diagnosis. Echocardiographic examination 
showed aortic and mitral regurgitation in 7, mitral 
regurgitation in 8 and aortic regurgitation in one 
patient. Serum levels of creatin phosphokinase 
(CK) and MB (CK-MB) fraction and cardiac 
troponin-T were measured during the diagnosis 
before the initiation of treatment in all patients. 
None of the patients had clinically overt 
congestive heart failure.
Results: It was observed that CK and CK-MB 
levels were increased in one patient with carditis 
and arthritis while cardiac troponin-T levels were 
below the measurable levels in all patients.
Conclusion: We concluded that cardiac 
troponin-T measurement has no value in 
detecting the presence of carditis in rheumatic 
fever. This may result from absence of 
myocardial necrosis despite the presence of 
intense myocardial inflammation.
K e y  W o r d s :  Troponin, Rheumatic fever, 
Carditis, Echocardiography
IN T R O D U C T IO N
Acute rheumatic fever (ARF) is still prevalent and 
one of the leading causes of mortality and 
morbidity due to acquired heart disease in 
developing countries (1). The Jones criteria 
described by T. Duckett Jones in 1944; revised in 
1962 and updated in 1992 is the only method for 
clinical diagnosis (2, 3). Although these criteria 
provide easy clinical judgement; there are some 
difficult cases in which clear cut diagnosis is not 
possible (4). A laboratory test specific for the 
disease has not yet been found. Carditis is the 
most important manifestation for long term 
prognosis. The presence of carditis is diagnosed 
by auscultation findings and this may not be 
accurate enough. Echocardiographic 
examination in all patients with rheumatic fever 
may provide better decision making, but this may 
not be possible, especially in the underprivileged 
regions of developing countries.
(Accepted 16 February, 2001) Marmara Medical Journal 2001 ;14(2):84-88
84
Correspondance to: Figen Akalın, M.D. -  e.mail address: figenakalin@superonline.com
Troponin-T in rheumatic fever
Cardiac troponins are structural proteins that 
take place in actin myosin complex and play a 
role in myocardial contraction. The troponin 
molecule has three components: cardiac 
troponin-T (cTN-T) is the tropomyosine binding 
part, cardiac troponin-l (cTN-l) is the inhibitor 
part and cardiac troponin-C (cTN-C) is the 
calcium binding part (6). These proteins are 
found in the serum of patients after myocardial 
cell injury. Since the troponins in the skeletal 
and cardiac muscle cells have different molecular 
structures, the measurement of serum cardiac 
troponin levels gives specific information about 
myocardial necrosis (6). Troponin-T and 
troponin-l are routinely used in adult patients with 
acute coronary syndromes and they are found to 
be more specific than creatin kinase and MB 
Isoenzyme, previously used as biochemical 
markers of myocardial injury (6, 7). Serum 
troponin-T levels are also found to be elevated in 
patients with myocarditis (8).
Carditis of rheumatic fever is a pancarditis and 
involves the three layers of the heart including 
the myocardium (9). If a marker of myocardial 
involvement was found, it would be quite helpful 
for the management and follow-up of these 
patients. We considered whether troponin-T 
could provide such information and investigated 
the serum level of troponin-T in patients with ARF 
with and without carditis.
M A TER IA LS A N D  M E T H O D S
The study group consisted of all patients 
diagnosed with acute rheumatic fever according 
to Jones criteria in the Marmara University 
School of Medicine, Pediatric Cardiology Sub­
department, between January 1998 and 
December 1999.
After detailed history taking and physical 
examination, a telecardiogram, electrocardiogram, 
complete blood count, erythrocyte sedimentation 
rate, C-reactive protein, throat culture and 
antistreptolysine - O titers were obtained in all 
patients. Serum creatin kinase (CK) and creatin 
kinase MB fraction were measured and serum 
samples were separated and frozen at - 70°C 
during diagnosis before the initiation of 
antiinflammatory treatment.
All the patients underwent échocardiographie 
examination. Echocardiography was performed 
by using ATL Ultramark 9 machine equipped with 
2.5, 3.5 and 5 MHz transducers.
The presence of carditis was determined on 
clinical grounds, by auscultation of a new onset 
murmur suggestive of mitral or aortic 
regurgitation and/or pericardial friction rub or 
clinical evidence of heart failure. Patients with 
échocardiographie evidence of mitral 
regurgitation without auscultation findings were 
not accepted as having active carditis.
Serum troponin-T levels were measured after 
collection of a sufficient number of serum 
samples by using Elecsys Boehringer Mannheim 
ELISA kit and Elecsys 1010 analyser.
Serum samples were also taken from the healthy 
children evaluated for non-cardiac disease while 
drawing blood for routine test as a control group, 
and measurements were performed at the same 
time.
Troponin-T levels of the patients with and without 
carditis and the control group were compared. 
CK and CK-MB levels of the patients with and 
without carditis were compared by using Mann- 
Witney U test.
RESULTS
The study group included 21 patients. Twelve of 
them were girls and 9 of them were boys. Their 
ages ranged between 6 and 16.5 years (mean ± 
SD = 11.9 ± 2.5 yrs). All the patients had their 
first attack of rheumatic fever, none of them had 
a previous history of arthritis or carditis. The 
control group consisted of 5 girls and 5 boys 
between the ages of 5 and 16 years (mean ± SD 
= 11.4 ±3.5).
Seven patients had only arthritis as a major 
manifestation, 10 patients had both arthritis and 
carditis (previously healthy children with initial 
attack of active carditis with new onset murmur of 
mitral regurgitation and elevated acute phase 
reactants associated with overt clinical 
symptoms of arthritis), and 4 patients were 
presented with chorea. None of the patients 
with carditis had clinical signs of congestive
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heart failure. Antistreptolysine -  O titers were 
elevated in all patients except two with chorea. 
Erythrocyte sedimentation rate ranged between 
9 to 14 mm/hour (mean ± SD = 70.2 ± 41.3 
mm/h). PR interval ranged between 0.12 to
0.28 seconds (mean ± SD = 0.15 ± 0.04 sec).
Echocardiographic examination revealed both 
mitral and aortic regurgitation in seven patients, 
only mitral regurgitation in eight patients and only 
aortic regurgitation in one patient. In five patients, 
echocardiographic examination was normal 
without any valvular involvement. All patients 
with chorea had mild mitral regurgitation and two 
patients diagnosed to have only arthritis by 
clinical judgement also had mild mitral 
regurgitation. The mild mitral regurgitation found 
in patients without clinical carditis was not 
consistent with the physiologic trivial mitral 
regurgitation that can be found in normal 
individuals.
Serum CK and CK-MB levels were elevated in 
only one patient with carditis and arthritis. (CK = 
302 U/L and CK-MB = 46 U/L) and in one patient 
with arthritis only CK was elevated (348 U/L). 
Serum CK levels ranged between 13 and 348 
U/L; and CK-MB levels ranged between 0 and 
46/U/L. There was no statistically significant 
difference between the patients with carditis and 
without carditis in terms of CK and CK-MB levels. 
The serum cardiac troponin T levels were found 
to be under the measurable level (<0.01 ng/dl) in 
all subjects with or without carditis and the 
control group.
The summary of CK, CK-MB and Troponin T 
levels according to clinical involvement of the 
patients are given in the table I.
Table I.: CK, CK-MB- Troponin T levels of the patients according to their clinical Involvement.
Clinical manifestation N
(years)
Age
(M/F)
Gender 
(N: 5-130) 
(N:0-26)
CK (U/L) 
MB (U/L)
CK-
(ng/dl)
Troponin T
Arthritis 7 11.3±2.9 2/3 193.0±219.2 20.5±0.7 <0.01
Arthritis+Carditis 10 11.8±2.5 5/5 107.0±108.8 9.5±12.0 <0.01
Chorea 4 12.6±1.7 2/2 87.0±65.1 21.5±3.5 <0.01
Total 21 11.9±2.5 9/12 101.4±93.8 14.1 ±11.9 <0.01
Control group 10 11.4±3.5 5/5 - - <0.01
D IS C U S S IO N
Acute rheumatic fever is still the most important 
cause of acquired heart disease in developing 
countries. Although its incidence and severity 
has decreased in developed countries it is not 
entirely eradicated and may cause cardiac 
morbidity (10). The diagnosis of acute rheumatic 
fever is possible only on clinical grounds by using 
Jones criteria, no clinical or laboratory test 
pathognomonic for the disease has been found 
up to date (11). The Jones criteria has been 
revised and updated several times in order to 
increase sensitivity ad specificity, these criteria 
are quite helpful to the practitioners for decision 
making but there are some difficult cases in 
which clear cut diagnosis may be a problem (3,
4).
Carditis is the most important major criteria of 
ARF since it is the only one that causes 
permanent damage (12). It is found in up to 30- 
50 % of patients with ARF. The presence of 
carditis is determined by auscultation of apical 
systolic and/or basal diastolic murmurs, clinical 
diagnosis of pericarditis or unexplained 
congestive heart failure (12). However, 
echocardiographic findings are not always 
consistent with the clinical findings. Even 
experienced physicians may not detect valvular 
regurgitation during routine examination. Mitral 
regurgitation found in acute rheumatic fever is 
due to ventricular dilatation or restriction of the 
leaflet mobility in most of the cases and may 
disappear or decrease in severity during the 
follow-up (5). Various studies have demonstrated 
that many patients considered to have isolated 
arthritis or chorea had echocardiographic
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evidence of valvular involvement (12-14). We 
also found a similar result in our patients; four 
patients with chorea and two patients with 
isolated arthritis had mild mitral regurgitation 
revealed by echocardiograhy. It is harder to 
recognize a new attack in a patient with previous 
valvular disease. Although one may consider 
performing echocardiography in all patients with 
suspected ARF, it is not cost-effective and 
echocardiography may not be available in the 
rural areas of developing countries. Furthermore, 
echocardiography also has some pitfalls such as 
differentiation of physiologic mitral regurgitation
(15).
Thus, a biochemical marker specific for carditis 
would provide invaluable information for 
straightforward diagnosis of ARF in difficult 
cases. Cardiac troponin-T and troponin-l are 
found to be specific for myocardial cell injury in 
various disease states (16). They are also 
studied in pediatric age group and found to be 
elevated in myocardial necrosis due to trauma, 
cardiac surgery, neonatal ischemia, myocarditis 
and anthrayclin toxicity (17-21). However, our 
study demonstrated that no such increase in 
serum cardiac troponin-T levels occurs in 
patients with ARF even in the presence of 
carditis. Narula et al (22) have studied 
scintigraphic imaging of antimyosin antibodies for 
detection of carditis in patients with ARF and they 
could obtain a high degree of scintigraphic 
uptake only in patients with pericarditis and 
severe congestive heart failure. They concluded 
that this finding is due to the lack of myocardial 
cell necrosis in the carditis of ARF. Possibly it 
holds true for troponin-T measurements and 
rheumatic carditis does not cause troponin-T 
elevation since myocardial necrosis does not 
occur despite intensive inflammation in ARF. The 
clinical evidence of myocarditis is tachycardia or 
congestive heart failure, however; neither 
myocarditis nor pericarditis is considered as 
rheumatic carditis when valvular involvement is 
not present. Histologic findings specific for 
rheumatic myocarditis is Aschoff nodules and 
histiocyte infiltration but Narula et al (23) has 
found these typical findings in only 27% of the 
patients who had clearcut diagnosis of active 
rheumatic carditis according to revised Jones 
criteria. Some authors suggest that the term 
myocarditis is not appropriate for rheumatic 
myocarditis when Dallas criteria are used, since
distinctive findings of myocyte necrosis and 
associated lymphocyte infiltration is absent (23). 
In all other patients with myocardial injury due to 
for example ischemia, viral myocarditis, trauma 
or surgery, there is myocardial cell necrosis 
causing the release of intracellular ingredients, 
including cardiac troponins, into the circulation. 
Left ventricular functions are preserved even 
during the acute phase of the disease and 
decreased left ventricular shortening fraction is 
thought to be due to valvular lesions when 
present. This also indicates that acute rheumatic 
fever is an inflammatory disease rather than a 
degenerative one (5). Permanent sequela of ARF 
is due to endocardial damage healing with 
fibrosis, not to the myocardial necrosis. Our study 
group did not include patients with congestive 
heart failure and pericarditis in which troponin 
elevation would be a non-specific finding as 
previous studies have demonstrated (24). On the 
other hand, the number of the patients included 
is limited and this may be the cause of the 
negative result.
In conclusion, serum troponin-T level does not 
increase and is not beneficial in the diagnosis 
and follow-up of rheumatic carditis. Further 
investigation is necessary for assessment of 
the value of troponin measurements in 
childhood.
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